despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6.. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..

the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.�.